VA
ORTX

Vident Advisory’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Vident Advisory’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-11,270
Closed -$185K – 1461
2023
Q4 		$185K Buy
+11,270
New +$185K ﹤0.01% 1232